You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Improved Transit Rider Experience
SBC: MERCURY DATA SYSTEMS, INC. Topic: 121FT1We propose to develop an advanced navigation solution for public transportation passengers that will guide them from their origin to single or multiple destination points and across multiple modes of transportation. Passengers will simply need to enter their destination (and optionally a starting point) and the system will select optimal and alternative routes. The navigation software will run on ...
SBIR Phase I 2012 Department of Transportation -
Real Time Signal State Transition Software for ATC- NTCIP Interface
SBC: Advanced Technologies, Inc Topic: 06FH1Phase II Project Scope: ATI has developed an open source Signal Control Programming Environment (SCOPE) that ➢ Implements Actuated Control with Min Recall Mode, Max Recall Mode, Gap Out Mode, Max Out Mode, Presence Mode, Lane-by-Lane Control. ➢ Contains a Pretimed Mode allowing control of 3-leg, 4-leg, and Texas Diamond Intersections ➢ Can be easily ported to any operating system. ➢ Can ha ...
SBIR Phase II 2012 Department of Transportation -
Novel on-dose authentication to enhance pharmaceutical supply chain security
SBC: CERTIRX CORPORATION Topic: FDADESCRIPTION (provided by applicant): The counterfeit drug business originated with lifestyle drugs, such as the erectile dysfunction drug. Now, however, counterfeits in almost any therapeutic category may be purchased by Americans through internet pharmacies. In fact, the Pharmaceutical Safety Institute found in 2010 that counterfeits in the metabolic disease category grew fastest (2), with the tr ...
SBIR Phase I 2012 Department of Health and Human ServicesFood and Drug Administration -
Picture Me Alcohol Free: Engaging Youth in Community-Based Prevention
SBC: PREVENTION STRATEGIES, LLC Topic: NIAAADESCRIPTION (provided by applicant): This application proposes to build on the successful Phase I Picture Me Alcohol Free (PMAF) feasibility pilot study. PMAF is a community-based program designed to train groups of youth to a) represent contributing factors and consequences (e.g., social availability, alcohol-involved crashes) of underage drinking in their communities through a specific photograp ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Reduction of Dietary Oxalate
SBC: CAPTOZYME LLC Topic: NCCAMDESCRIPTION (provided by applicant): Kidney stones are a common and painful human health care problem worldwide. Of all stones developed approximately 75% are composed of calcium oxalate. Urinary oxalate is regarded as a driving force for calcium oxalate stone formation, and absorption of dietary oxalate contributes to 10-70% of urinary oxalate. In fact, roughly 2.4 million Americans (0.75% of the ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
A Needle Guidance System for Hepatic Tumor Ablation That Fuses Real-Time Ultrasou
SBC: INNEROPTIC TECHNOLOGY INC Topic: NCIDESCRIPTION (provided by applicant): We propose to develop an operating-room-ready system for needle guidance in soft tissue, which fuses intra- operative ultrasound and pre-operative X-ray computed tomography (CT) data by combining two novel technologies:1) a radically different way of visualizing and interacting with the fused ultrasound and CT images, which we call Spotlight ; and 2) an innova ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Development of Wnt Pathway Inhibitors for Colorectal Cancer
SBC: Stemsynergy Therapeutic Topic: NCIDESCRIPTION (provided by applicant): StemSynergy Therapeutics Inc. (SSTI) is a biopharmaceutical company focused on the discovery, development, and commercialization of drugs that target pathways fundamental to stem cells and cancer stem cells. The WorldHealth Organization estimates that over 12 million cases of cancer were diagnosed in 2007 and that nearly 8 million cancer patients will die of t ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Melanocortin Ligands in Disease Cachexia
SBC: TENSIVE CONTROLS, INC. Topic: NCIDESCRIPTION (provided by applicant): Cachexia-anorexia syndrome is a life-threatening aspect to many diseases, in particular many forms of cancer or therapies for cancer. The obvious symptoms of this disease include lack of appetite, and a loss of lean body mass disproportionate to the reduction in caloric intake. However, the less obvious effects include multi-organ failure, due to high metabolic ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies
SBC: Woomera Therapeutics, Inc. Topic: NCIDESCRIPTION (provided by applicant): There is currently no effective treatment for recurrent small-cell lung cancer (rSCLC). The objective of this project is to utilize a monoclonal antibody, Abner, to develop new, rational, and successful treatment of rSCLC. The hypothesis being tested is that an abnormal vasopressin type 2 receptor (AbnV2R) present on these tumors will provide a sensitive, tumor ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Quick-Set Material-Phase II
SBC: PRIMUS CONSULTING Topic: NIDCRDESCRIPTION (provided by applicant): Quick-Set Material- Phase II Quick-Set material is proposed for vital pulp therapy and for non-vital endodontic use to make the clinical procedures shorter and more consistent, of benefit to the patient and clinician,and enhance the probability for a positive outcome. The new material should promote regeneration of the periodontal ligament and cemental tissues ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health